Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial F₀F₁-adenosine triphosphatase (F₀F₁-ATPase) is a multi-subunit enzyme complex essential for energy metabolism and pH homeostasis in oral bacteria, particularly acidogenic species like Streptococcus mutans [1]. In the context of the oral cavity, this enzyme primarily functions as a proton pump that utilizes ATP hydrolysis to expel protons from the bacterial cell, maintaining a relatively neutral internal pH despite an acidic external environment [2]. This acid-tolerance mechanism is a key virulence factor, as it allows cariogenic bacteria to survive and thrive in low-pH conditions created by their own fermentative metabolism [3]. By maintaining the intracellular environment, the enzyme supports the continued production of organic acids that lead to the demineralization of tooth enamel [4]. Inhibition of F₀F₁-ATPase disrupts this pH regulation, making the bacteria susceptible to acid-induced damage and significantly reducing their competitive fitness within dental biofilms [5]. Various compounds, including fluoride and certain plant-derived polyphenols like those found in cranberries, have been shown to inhibit this enzyme's activity [6]. Targeting this enzyme represents a strategic approach in oral health to selectively impair the fitness of pathogenic, acid-tolerant bacteria without necessarily killing the entire oral microbiome [7]. Because of its structural differences from human mitochondrial ATP synthase, it serves as a viable target for narrow-spectrum antimicrobial interventions [8]. [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC94591/ [2] https://journals.asm.org/doi/10.1128/jb.184.21.5903-5911.2002 [3] https://pubmed.ncbi.nlm.nih.gov/11806968/ [4] https://pubmed.ncbi.nlm.nih.gov/16151009/ [5] https://pubmed.ncbi.nlm.nih.gov/20443603/ [6] https://pubmed.ncbi.nlm.nih.gov/15814820/ [7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133681/ [8] https://pubmed.ncbi.nlm.nih.gov/12417578/
Inhibition of the proton-translocating pore or the catalytic subunits to prevent proton extrusion, leading to intracellular acidification and bacterial death.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial F₀F₁-adenosine triphosphatase (F₀F₁-ATPase) (F₀F₁-ATPase).